• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Immaculata De Vivo, MPH, PhD

Publications

  • Setiawan VW, Schumacher F, Prescott J, Haessler J, Malinowski J, Wentzensen N, Yang H, Chanock S, Brinton L, Hartge P, Lissowska J, Park SL, Cheng I, Bush WS, Crawford DC, Ursin G, Horn-Ross P, Bernstein L, Lu L, Risch H, Yu H, Sakoda LC, Doherty J, Chen C, Jackson R, Yasmeen S, Cote M, Kocarnik JM, Peters U, Kraft P, De Vivo I, Haiman CA, Kooperberg C, Le Marchand L.Cross-cancer pleiotropic analysis of endometrial cancer: PAGE and E2C2 consortia.Carcinogenesis. 2014 May 15.
    24832084
  • Prescott J, Bao Y, Viswanathan AN, Giovannucci EL, Hankinson SE, De Vivo I.Dietary insulin index and insulin load in relation to endometrial cancer risk in the Nurses' Health Study.Cancer Epidemiol Biomarkers Prev. 2014 May 23.
    24859872
  • Chen MM, Crous-Bou M, Setiawan VW, Prescott J, Olson SH, Wentzensen N, Black A, Brinton L, Chen C, Chen C, Cook LS, Doherty J, Friedenreich CM, Hankinson SE, Hartge P, Henderson BE, Hunter DJ, Le Marchand L, Liang X, Lissowska J, Lu L, Orlow I, Petruzella S, Polidoro S, Pooler L, Rebbeck TR, Risch H, Sacerdote C, Schumacher F, Sheng X, Shu XO, Weiss NS, Xia L, Van Den Berg D, Yang HP, Yu H, Chanock S, Haiman C, Kraft P, De Vivo I.Exome-wide association study of endometrial cancer in a multiethnic population.PLoS ONE. 2014;9(5):e97045.
    24810602
  • Rewak M, Buka S, Prescott J, De Vivo I, Loucks EB, Kawachi I, Non AL, Kubzansky LD.Race-related health disparities and biological aging: Does rate of telomere shortening differ across blacks and whites?.Biol Psychol. 2014 Mar 29;99C:92-99.
    24686071
  • Figueroa JD, Han SS, Garcia-Closas M, Baris D, Jacobs EJ, Kogevinas M, Schwenn M, Malets N, Johnson A, Purdue MP, Caporaso N, Landi MT, Prokunina-Olsson L, Wang Z, Hutchinson A, Burdette L, Wheeler W, Vineis P, Siddiq A, Cortessis VK, Kooperberg C, Cussenot O, Benhamou S, Prescott J, Porru S, Bueno-de-Mesquita HB, Trichopoulos D, Ljungberg B, Clavel-Chapelon F, Weiderpass E, Krogh V, Dorronsoro M, Travis R, Tjønneland A, Brenan P, Chang-Claude J, Riboli E, Conti DV, Gago-Dominguez M, Stern MC, Pike MC, Van Den Berg D, Yuan JM, Hohensee C, Rodabough R, Cancel-Tassin G, Roupret M, Comperat E, Chen C, De Vivo I, Giovannucci E, Hunter DJ, Kraft P, Lindstrom S, Carta A, Pavanello S, Arici C, Mastrangelo G, Karagas MR, Schned A, Armenti KR, Hosain M, Haiman CA, Fraumeni JF, Chanock SJ, Chatterjee N, Rothman N, Silverman DT.Genome-wide interaction study of smoking and bladder cancer risk.Carcinogenesis. 2014 Mar 24.
    24662972
  • Qi Q, Chu AY, Kang JH, Huang J, Rose LM, Jensen MK, Liang L, Curhan GC, Pasquale LR, Wiggs JL, De Vivo I, Chan AT, Choi HK, Tamimi RM, Ridker PM, Hunter DJ, Willett WC, Rimm EB, Chasman DI, Hu FB, Qi L.Fried food consumption, genetic risk, and body mass index: gene-diet interaction analysis in three US cohort studies.BMJ. 2014;348:g1610.
    24646652
  • Du M, Kraft P, Eliassen AH, Giovannucci E, Hankinson SE, De Vivo I.Physical activity and risk of endometrial adenocarcinoma in the Nurses' Health Study.Int J Cancer. 2014 Jun 1;134(11):2707-16.
    24213924
  • Wong JY, De Vivo I, Lin X, Grashow R, Cavallari J, Christiani DC.The association between global DNA methylation and telomere length in a longitudinal study of boilermakers.Genet Epidemiol. 2014 Apr;38(3):254-64.
    24616077
  • Wong JY, De Vivo I, Lin X, Christiani DC.Cumulative PM(2.5) exposure and telomere length in workers exposed to welding fumes.J. Toxicol. Environ. Health Part A. 2014;77(8):441-55.
    24627998
  • Figueroa JD, Ye Y, Siddiq A, Garcia-Closas M, Chatterjee N, Prokunina-Olsson L, Cortessis VK, Kooperberg C, Cussenot O, Benhamou S, Prescott J, Porru S, Dinney CP, Malats N, Baris D, Purdue M, Jacobs EJ, Albanes D, Wang Z, Deng X, Chung CC, Tang W, Bas Bueno-de-Mesquita H, Trichopoulos D, Ljungberg B, Clavel-Chapelon F, Weiderpass E, Krogh V, Dorronsoro M, Travis R, Tjønneland A, Brenan P, Chang-Claude J, Riboli E, Conti D, Gago-Dominguez M, Stern MC, Pike MC, Van Den Berg D, Yuan JM, Hohensee C, Rodabough R, Cancel-Tassin G, Roupret M, Comperat E, Chen C, De Vivo I, Giovannucci E, Hunter DJ, Kraft P, Lindstrom S, Carta A, Pavanello S, Arici C, Mastrangelo G, Kamat AM, Lerner SP, Barton Grossman H, Lin J, Gu J, Pu X, Hutchinson A, Burdette L, Wheeler W, Kogevinas M, Tardón A, Serra C, Carrato A, García-Closas R, Lloreta J, Schwenn M, Karagas MR, Johnson A, Schned A, Armenti KR, Hosain GM, Andriole G, Grubb R, Black A, Ryan Diver W, Gapstur SM, Weinstein SJ, Virtamo J, Haiman CA, Landi MT, Caporaso N, Fraumeni JF, Vineis P, Wu X, Silverman DT, Chanock S, Rothman N.Genome-wide association study identifies multiple loci associated with bladder cancer risk.Hum Mol Genet. 2014 Mar 1;23(5):1387-98.
    24163127
  • Wong JY, De Vivo I, Lin X, Fang SC, Christiani DC.The relationship between inflammatory biomarkers and telomere length in an occupational prospective cohort study.PLoS ONE. 2014;9(1):e87348.
    24475279
  • De Vivo I, Prescott J, Setiawan VW, Olson SH, Wentzensen N, , Attia J, Black A, Brinton L, Chen C, Chen C, Cook LS, Crous-Bou M, Doherty J, Dunning AM, Easton DF, Friedenreich CM, Garcia-Closas M, Gaudet MM, Haiman C, Hankinson SE, Hartge P, Henderson BE, Holliday E, Horn-Ross PL, Hunter DJ, Le Marchand L, Liang X, Lissowska J, Long J, Lu L, Magliocco AM, McEvoy M, O'Mara TA, Orlow I, Painter JN, Pooler L, Rastogi R, Rebbeck TR, Risch H, Sacerdote C, Schumacher F, Scott RJ, Sheng X, Shu XO, Spurdle AB, Thompson D, Vanden Berg D, Weiss NS, Xia L, Xiang YB, Yang HP, Yu H, Zheng W, Chanock S, Kraft P.Genome-wide association study of endometrial cancer in E2C2.Hum Genet. 2014 Feb;133(2):211-24.
    24096698
  • Walcott F, Rajaraman P, Gadalla SM, Inskip PD, Purdue MP, Albanes D, Orr E, De Vivo I, Savage SA.Telomere length and risk of glioma.Cancer Epidemiology. 2013 Dec;37(6):935-8.
    24231251
  • Burke LS, Hyland PL, Pfeiffer RM, Prescott J, Wheeler W, Mirabello L, Savage SA, Burdette L, Yeager M, Chanock S, De Vivo I, Tucker MA, Goldstein AM, Yang XR.Telomere length and the risk of cutaneous malignant melanoma in melanoma-prone families with and without CDKN2A mutations.PLoS ONE. 2013;8(8):e71121.
    23990928
  • Kang JH, Kueck AS, Stevens R, Curhan G, De Vivo I, Rosner B, Alexander E, Tworoger SS.A large cohort study of hypothyroidism and hyperthyroidism in relation to gynecologic cancers.Obstet Gynecol Int. 2013;2013:743721.
    23956749
  • Hoge EA, Chen MM, Orr E, Metcalf CA, Fischer LE, Pollack MH, De Vivo I, Simon NM.Loving-Kindness Meditation practice associated with longer telomeres in women.Brain Behav Immun. 2013 Aug;32:159-63.
    23602876
  • Liu JJ, Prescott J, Giovannucci E, Hankinson SE, Rosner B, Han J, De Vivo I.Plasma Vitamin D Biomarkers and Leukocyte Telomere Length.Am J Epidemiol. 2013 May 9.
    23660800
  • Garcia-Closas M, Rothman N, Figueroa JD, Prokunina-Olsson L, Han SS, Baris D, Jacobs EJ, Malats N, De Vivo I, Albanes D, Purdue MP, Sharma S, Fu YP, Kogevinas M, Wang Z, Tang W, Tardón A, Serra C, Carrato A, García-Closas R, Lloreta J, Johnson A, Schwenn M, Karagas MR, Schned A, Andriole G, Grubb R, Black A, Gapstur SM, Thun M, Diver WR, Weinstein SJ, Virtamo J, Hunter DJ, Caporaso N, Landi MT, Hutchinson A, Burdett L, Jacobs KB, Yeager M, Fraumeni JF, Chanock SJ, Silverman DT, Chatterjee N.Common Genetic Polymorphisms Modify the Effect of Smoking on Absolute Risk of Bladder Cancer.Cancer Res. 2013 Apr 1;73(7):2211-2220.
    23536561
  • Liu JJ, Prescott J, Giovannucci E, Hankinson SE, Rosner B, De Vivo I.One-carbon metabolism factors and leukocyte telomere length1,3.Am J Clin Nutr. 2013 Apr;97(4):794-9.
    23446900
  • Setiawan VW, Pike MC, Karageorgi S, Deming SL, Anderson K, Bernstein L, Brinton LA, Cai H, Cerhan JR, Cozen W, Chen C, Doherty J, Freudenheim JL, Goodman MT, Hankinson SE, Lacey JV, Liang X, Lissowska J, Lu L, Lurie G, Mack T, Matsuno RK, McCann S, Moysich KB, Olson SH, Rastogi R, Rebbeck TR, Risch H, Robien K, Schairer C, Shu XO, Spurdle AB, Strom BL, Thompson PJ, Ursin G, Webb PM, Weiss NS, Wentzensen N, Xiang YB, Yang HP, Yu H, Horn-Ross PL, De Vivo I, .Age at last birth in relation to risk of endometrial cancer: pooled analysis in the epidemiology of endometrial cancer consortium.Am J Epidemiol. 2012 Aug 15;176(4):269-78.
    22831825
  • Prescott J, Thompson DJ, Kraft P, Chanock SJ, Audley T, Brown J, Leyland J, Folkerd E, Doody D, Hankinson SE, Hunter DJ, Jacobs KB, Dowsett M, Cox DG, Easton DF, De Vivo I.Genome-wide association study of circulating estradiol, testosterone, and sex hormone-binding globulin in postmenopausal women.PLoS ONE. 2012;7(6):e37815.
    22675492
  • Karageorgi S, McGrath M, Lee IM, Buring J, Kraft P, De Vivo I.Polymorphisms in genes hydroxysteroid-dehydrogenase-17b type 2 and type 4 and endometrial cancer risk.Gynecol Oncol. 2011 Apr;121(1):54-8.
    21129770
  • Liang GY, Qureshi AA, Guo Q, Vivo ID, Han J.No Association between Telomere Length in Peripheral Blood Leukocytes and the Risk of Non-melanoma Skin Cancer.Cancer Epidemiol Biomarkers Prev. 2011 Feb 25.
    21357377
  • Lurie G, Gaudet MM, Spurdle AB, Carney ME, Wilkens LR, Yang HP, Weiss NS, Webb PM, Thompson PJ, Terada K, Setiawan VW, Rebbeck TR, Prescott J, Orlow I, O'Mara T, Olson SH, Narod SA, Matsuno RK, Lissowska J, Liang X, Levine DA, Le Marchand L, Kolonel LN, Henderson BE, Garcia-Closas M, Doherty JA, De Vivo I, Chen C, Brinton LA, Akbari MR, , , Goodman MT.The obesity-associated polymorphisms FTO rs9939609 and MC4R rs17782313 and endometrial cancer risk in non-Hispanic white women.PLoS ONE. 2011;6(2):e16756.
    21347432
  • Nan H, Qureshi AA, Prescott J, De Vivo I, Han J.Genetic variants in telomere-maintaining genes and skin cancer risk.Hum Genet. 2011 Mar;129(3):247-53.
    21116649
  • McGrath M, Lee IM, Buring J, De Vivo I.Common genetic variation within IGFI, IGFII, IGFBP-1, and IGFBP-3 and endometrial cancer risk.Gynecol Oncol. 2011 Feb;120(2):174-8.
    21078522
  • Rothman N, Garcia-Closas M, Chatterjee N, Malats N, Wu X, Figueroa JD, Real FX, Van Den Berg D, Matullo G, Baris D, Thun M, Kiemeney LA, Vineis P, De Vivo I, Albanes D, Purdue MP, Rafnar T, Hildebrandt MA, Kiltie AE, Cussenot O, Golka K, Kumar R, Taylor JA, Mayordomo JI, Jacobs KB, Kogevinas M, Hutchinson A, Wang Z, Fu YP, Prokunina-Olsson L, Burdett L, Yeager M, Wheeler W, Tardón A, Serra C, Carrato A, García-Closas R, Lloreta J, Johnson A, Schwenn M, Karagas MR, Schned A, Andriole G, Grubb R, Black A, Jacobs EJ, Diver WR, Gapstur SM, Weinstein SJ, Virtamo J, Cortessis VK, Gago-Dominguez M, Pike MC, Stern MC, Yuan JM, Hunter DJ, McGrath M, Dinney CP, Czerniak B, Chen M, Yang H, Vermeulen SH, Aben KK, Witjes JA, Makkinje RR, Sulem P, Besenbacher S, Stefansson K, Riboli E, Brennan P, Panico S, Navarro C, Allen NE, Bueno-de-Mesquita HB, Trichopoulos D, Caporaso N, Landi MT, Canzian F, Ljungberg B, Tjonneland A, Clavel-Chapelon F, Bishop DT, Teo MT, Knowles MA, Guarrera S, Polidoro S, Ricceri F, Sacerdote C, Allione A, Cancel-Tassin G, Selinski S, Hengstler JG, Dietrich H, Fletcher T, Rudnai P, Gurzau E, Koppova K, Bolick SC, Godfrey A, Xu Z, Sanz-Velez JI, D García-Prats M, Sanchez M, Valdivia G, Porru S, Benhamou S, Hoover RN, Fraumeni JF, Silverman DT, Chanock SJ.A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci.Nat Genet. 2010 Nov;42(11):978-84.
    20972438
  • Prescott J, McGrath M, Lee IM, Buring JE, De Vivo I.Telomere length and genetic analyses in population-based studies of endometrial cancer risk.Cancer. 2010 Sep 15;116(18):4275-82.
    20549820
  • Mirabello L, Yu K, Kraft P, De Vivo I, Hunter DJ, Prescott J, Wong JY, Chatterjee N, Hayes RB, Savage SA.The association of telomere length and genetic variation in telomere biology genes.Hum Mutat. 2010 Sep;31(9):1050-8.
    20597107
  • Zeleniuch-Jacquotte A, Gallicchio L, Hartmuller V, Helzlsouer KJ, McCullough ML, Setiawan VW, Shu XO, Weinstein SJ, Weiss JM, Arslan AA, De Vivo I, Gao YT, Hayes RB, Henderson BE, Horst RL, Koenig KL, Patel AV, Purdue MP, Snyder K, Steplowski E, Yu K, Zheng W, Hankinson SE.Circulating 25-hydroxyvitamin D and risk of endometrial cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.Am J Epidemiol. 2010 Jul 1;172(1):36-46.
    20562189
  • Karageorgi S, Gates MA, Hankinson SE, De Vivo I.Perineal Use of Talcum Powder and Endometrial Cancer Risk.Cancer Epidemiol Biomarkers Prev. 2010 May;19(5):1269-75.
    20406962
  • Cassidy A, De Vivo I, Liu Y, Han J, Prescott J, Hunter DJ, Rimm EB.Associations between diet, lifestyle factors, and telomere length in women.Am J Clin Nutr. 2010 May;91(5):1273-80.
    20219960
  • Terry K, McGrath M, Lee IM, Buring J, De Vivo I.Genetic variation in CYP11A1 and StAR in relation to endometrial cancer risk.Gynecol Oncol. 2010 May;117(2):255-9.
    20199803
  • Karageorgi S, Hankinson SE, Kraft P, De Vivo I.Reproductive factors and postmenopausal hormone use in relation to endometrial cancer risk in the Nurses' Health Study cohort 1976-2004.Int J Cancer. 2010 Jan 1;126(1):208-16.
    19551854
  • Ogino S, Nosho K, Shima K, Baba Y, Irahara N, Kirkner GJ, Hazra A, De Vivo I, Giovannucci EL, Meyerhardt JA, Fuchs CS.p21 expression in colon cancer and modifying effects of patient age and body mass index on prognosis.Cancer Epidemiol Biomarkers Prev. 2009 Sep;18(9):2513-21.
    19723919
  • Song H, Ramus SJ, Tyrer J, Bolton KL, Gentry-Maharaj A, Wozniak E, Anton-Culver H, Chang-Claude J, Cramer DW, DiCioccio R, Dörk T, Goode EL, Goodman MT, Schildkraut JM, Sellers T, Baglietto L, Beckmann MW, Beesley J, Blaakaer J, Carney ME, Chanock S, Chen Z, Cunningham JM, Dicks E, Doherty JA, Dürst M, Ekici AB, Fenstermacher D, Fridley BL, Giles G, Gore ME, De Vivo I, Hillemanns P, Hogdall C, Hogdall E, Iversen ES, Jacobs IJ, Jakubowska A, Li D, Lissowska J, Lubiński J, Lurie G, McGuire V, McLaughlin J, Medrek K, Moorman PG, Moysich K, Narod S, Phelan C, Pye C, Risch H, Runnebaum IB, Severi G, Southey M, Stram DO, Thiel FC, Terry KL, Tsai YY, Tworoger SS, Van Den Berg DJ, Vierkant RA, Wang-Gohrke S, Webb PM, Wilkens LR, Wu AH, Yang H, Brewster W, Ziogas A, , , , Houlston R, Tomlinson I, Whittemore AS, Rossing MA, Ponder BA, Pearce CL, Ness RB, Menon U, Kjaer SK, Gronwald J, Garcia-Closas M, Fasching PA, Easton DF, Chenevix-Trench G, Berchuck A, Pharoah PD, Gayther SA.A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2.Nat Genet. 2009 Sep;41(9):996-1000.
    19648919
  • Mirabello L, Huang WY, Wong JY, Chatterjee N, Reding D, Crawford ED, De Vivo I, Hayes RB, Savage SA.The association between leukocyte telomere length and cigarette smoking, dietary and physical variables, and risk of prostate cancer.Aging Cell. 2009 Aug;8(4):405-13.
    19493248
  • Kotsopoulos J,Tworoger SS,Devivo I,Hankinson SE,Hunter DJ,Willett WC,Chen WY.+331G/A variant in the progesterone receptor gene, postmenopausal hormone use and risk of breast cancer.Int J Cancer. 2009 Oct 1;125(7):1685-91.
    19462450
  • Karlson EW, Chibnik LB, McGrath M, Chang SC, Keenan BT, Costenbader KH, Fraser PA, Tworoger S, Hankinson SE, Lee IM, Buring J, De Vivo I.A prospective study of androgen levels, hormone-related genes and risk of rheumatoid arthritis.Arthritis Res Ther. 2009;11(3):R97.
    19555469
  • McGrath M,Lepine J,Lee IM,Villeneuve L,Buring J,Guillemette C,De Vivo I.Genetic variations in UGT1A1 and UGT2B7 and endometrial cancer risk.Pharmacogenet Genomics. 2009 Mar;19(3):239-43.
    19352303
  • De Vivo I,Prescott J,Wong JY,Kraft P,Hankinson SE,Hunter DJ.A prospective study of relative telomere length and postmenopausal breast cancer risk.Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1152-6.
    19293310
  • Olson SH,Chen C,De Vivo I,Doherty JA,Hartmuller V,Horn-Ross PL,Lacey JV Jr,Lynch SM,Sansbury L,Setiawan VW,Schouten LJ,Shu XO.Maximizing resources to study an uncommon cancer: E2C2--Epidemiology of Endometrial Cancer Consortium.Cancer Causes Control. 2009 May;20(4):491-6.
    19132539
  • Setiawan VW,Doherty JA,Shu XO,Akbari MR,Chen C,De Vivo I,Demichele A,Garcia-Closas M,Goodman MT,Haiman CA,Hankinson SE,Henderson BE,Horn-Ross PL,Lacey JV Jr,Le Marchand L,Levine DA,Liang X,Lissowska J,Lurie G,McGrath M,Narod SA,Rebbeck TR,Ursin G,Weiss NS,Xiang YB,Yang HP,Zheng W,Olson SH.Two estrogen-related variants in CYP19A1 and endometrial cancer risk: a pooled analysis in the Epidemiology of Endometrial Cancer Consortium.Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):242-7.
    19124504
  • Gates MA,Tworoger SS,Terry KL,De Vivo I,Hunter DJ,Hankinson SE,Cramer DW.Breast cancer susceptibility alleles and ovarian cancer risk in 2 study populations.Int J Cancer. 2009 Feb 1;124(3):729-33.
    18973230
  • Kotsopoulos J,Vitonis AF,Terry KL,De Vivo I,Cramer DW,Hankinson SE,Tworoger SS.Coffee intake, variants in genes involved in caffeine metabolism, and the risk of epithelial ovarian cancer.Cancer Causes Control. 2009 Apr;20(3):335-44.
    18941913
  • McGrath M,Lee IM,Buring J,Hunter DJ,De Vivo I.Novel breast cancer risk alleles and endometrial cancer risk.Int J Cancer. 2008 Dec 15;123(12):2961-4.
    18785201
  • Gates MA,Tworoger SS,Terry KL,Titus-Ernstoff L,Rosner B,De Vivo I,Cramer DW,Hankinson SE.Talc use, variants of the GSTM1, GSTT1, and NAT2 genes, and risk of epithelial ovarian cancer.Cancer Epidemiol Biomarkers Prev. 2008 Sep;17(9):2436-44.
    18768514
  • Ter-Minassian M,Zhai R,Asomaning K,Su L,Zhou W,Liu G,Heist RS,Lynch TJ,Wain JC,Lin X,De Vivo I,Christiani DC.Apoptosis gene polymorphisms, age, smoking and the risk of non-small cell lung cancer.Carcinogenesis. 2008 Nov;29(11):2147-52.
    18757527
  • Shammas MA,Qazi A,Batchu RB,Bertheau RC,Wong JY,Rao MY,Prasad M,Chanda D,Ponnazhagan S,Anderson KC,Steffes CP,Munshi NC,De Vivo I,Beer DG,Gryaznov S,Weaver DW,Goyal RK.Telomere maintenance in laser capture microdissection-purified Barrett's adenocarcinoma cells and effect of telomerase inhibition in vivo.Clin Cancer Res. 2008 Aug 1;14(15):4971-80.
    18676772
  • Han J,Qureshi AA,Prescott J,Guo Q,Ye L,Hunter DJ,De Vivo I.A prospective study of telomere length and the risk of skin cancer.J Invest Dermatol. 2009 Feb;129(2):415-21.
    18668136
  • Wong JY, Huggins GS, Debidda M, Munshi NC, De Vivo I.Dichloroacetate induces apoptosis in endometrial cancer cells.Gynecol Oncol. 2008 Jun;109(3):394-402.
    18423823
  • Terry K, McGrath M, Lee IM, Buring J, De Vivo I.MDM2 SNP309 Is Associated with Endometrial Cancer Risk.Cancer Epidemiol Biomarkers Prev. 2008 Apr;17(4):983-6.
    18398041
  • Crous-Bou M, De Vivo I, Porta M, Pumarega JA, Lopez T, Alguacil J, Morales E, Malats N, Rifa J, Hunter DJ, Real FX.CYP1B1 Polymorphisms and K-ras Mutations in Patients with Pancreatic Ductal Adenocarcinoma.Dig Dis Sci. 2008 May;53(5):1417-1421.
    18347981
  • Terry KL, Missmer SA, Hankinson SE, Willett WC, De Vivo I.Lycopene and other carotenoid intake in relation to risk of uterine leiomyomata.Am J Obstet Gynecol. 2008 Jan;198(1):37.e1-8.
    17981250
  • Terry KL, De Vivo I, Hankinson SE, Spiegelman D, Wise LA, Missmer SA.Anthropometric characteristics and risk of uterine leiomyoma.Epidemiology. 2007 Nov;18(6):758-63.
    17917603
  • Gates MA, Tworoger SS, Hecht JL, De Vivo I, Rosner B, Hankinson SE.A prospective study of dietary flavonoid intake and incidence of epithelial ovarian cancer.Int J Cancer. 2007 Nov 15;121(10):2225-32.
    17471564
  • McGrath M, Hankinson SE, De Vivo I.Cytochrome P450 1A1, cigarette smoking, and risk of endometrial cancer (United States).Cancer Causes Control. 2007 Dec;18(10):1123-30.
    17717632
  • McGrath M, Hankinson SE, De Vivo I.Cytochrome P450 1A1, cigarette smoking, and risk of endometrial cancer (United States).Cancer Causes Control.;10:1123-30.
  • Cox DG, Deer D, Guo Q, Tworoger SS, Hankinson SE, Hunter DJ, De Vivo I.The p53 Arg72Pro and MDM2 -309 polymorphisms and risk of breast cancer in the nurses' health studies.Cancer Causes Control. 2007 Aug;18(6):621-5.
    17387621
  • McGrath M, Wong JY, Michaud D, Hunter DJ, De Vivo I.Telomere length, cigarette smoking, and bladder cancer risk in men and women.Cancer Epidemiol Biomarkers Prev. 2007 Apr;16(4):815-9.
    17416776
  • Angioli R, Palaia I, Calcagno M, Manci N, Zullo MA, Bellati F, Perniola G, de Vivo A, Benedetti Panici P.Liposome-encapsulated doxorubicin citrate in previously treated recurrent/metastatic gynecological malignancies.Int J Gynecol Cancer. 2007 Jan-Feb;17(1):88-93.
    17291237
  • Genkinger JM, DeVivo I, Stampfer MJ, Giovannucci E, Michaud DS.Nonsteroidal antiinflammatory drug use and risk of bladder cancer in the health professionals follow-up study.Int J Cancer. 2007 May 15;120(10):2221-5.
    17290403
  • Han J, Hankinson SE, De Vivo I.Polymorphisms in O6-methylguanine DNA methyltransferase and endometrial cancer risk.Carcinogenesis. 2006 Nov;27(11):2281-5.
    16777993
  • McGrath M, Michaud D, De Vivo I.Polymorphisms in GSTT1, GSTM1, NAT1 and NAT2 genes and bladder cancer risk in men and women.BMC Cancer. 2006;6:239.
    17026750
  • Pignata S, Scambia G, Savarese A, Breda E, Scollo P, De Vivo R, Rossi E, Gebbia V, Natale D, Del Gaizo F, Naglieri E, Ferro A, Musso P, D'Arco AM, Sorio R, Pisano C, Di Maio M, Signoriello G, Annunziata A, Perrone F,.Safety of a 3-weekly schedule of carboplatin plus pegylated liposomal doxorubicin as first line chemotherapy in patients with ovarian cancer: preliminary results of the MITO-2 randomized trial.BMC Cancer. 2006;6:202.
    16882344
  • Huggins GS, Wong JY, Hankinson SE, De Vivo I.GATA5 activation of the progesterone receptor gene promoter in breast cancer cells is influenced by the +331G/A polymorphism.Cancer Res. 2006 Feb 1;66(3):1384-90.
    16452193
  • McGrath M, Lee IM, Hankinson SE, Kraft P, Hunter DJ, Buring J, De Vivo I.Androgen receptor polymorphisms and endometrial cancer risk.Int J Cancer. 2006 Mar 1;118(5):1261-8.
    16161040
  • McGrath M, Michaud DS, De Vivo I.Hormonal and reproductive factors and the risk of bladder cancer in women.Am J Epidemiol. 2006 Feb 1;163(3):236-44.
    16319290
  • Holick CN, De Vivo I, Feskanich D, Giovannucci E, Stampfer M, Michaud DS.Intake of fruits and vegetables, carotenoids, folate, and vitamins A, C, E and risk of bladder cancer among women (United States).Cancer Causes Control. 2005 Dec;16(10):1135-45.
    16215863
  • Michaud DS, De Vivo I, Morris JS, Giovannucci E.Toenail selenium concentrations and bladder cancer risk in women and men.Br J Cancer. 2005 Oct 3;93(7):804-6.
    16175184
  • Paynter RA, Hankinson SE, Colditz GA, Kraft P, Hunter DJ, De Vivo I.CYP19 (aromatase) haplotypes and endometrial cancer risk.Int J Cancer. 2005 Aug 20;116(2):267-74.
    15800924
  • Terry KL, De Vivo I, Titus-Ernstoff L, Sluss PM, Cramer DW.Genetic variation in the progesterone receptor gene and ovarian cancer risk.Am J Epidemiol. 2005 Mar 1;161(5):442-51.
    15718480
  • Viswanathan AN, Feskanich D, De Vivo I, Hunter DJ, Barbieri RL, Rosner B, Colditz GA, Hankinson SE.Smoking and the risk of endometrial cancer: results from the Nurses' Health Study.Int J Cancer. 2005 May 10;114(6):996-1001.
    15645490
  • Paynter RA, Hankinson SE, Colditz GA, Hunter DJ, De Vivo I.No evidence of a role for PPARgamma Pro12Ala polymorphism in endometrial cancer susceptibility.Pharmacogenetics. 2004 Dec;14(12):851-6.
    15608564
  • Han J, Hankinson SE, Zhang SM, De Vivo I, Hunter DJ.Interaction between genetic variations in DNA repair genes and plasma folate on breast cancer risk.Cancer Epidemiol Biomarkers Prev. 2004 Apr;13(4):520-4.
    15066914
  • Setiawan VW, Hankinson SE, Colditz GA, Hunter DJ, De Vivo I.HSD17B1 gene polymorphisms and risk of endometrial and breast cancer.Cancer Epidemiol Biomarkers Prev. 2004 Feb;13(2):213-9.
    14973105
  • Han J, Hankinson SE, Hunter DJ, De Vivo I.Genetic variations in XRCC2 and XRCC3 are not associated with endometrial cancer risk.Cancer Epidemiol Biomarkers Prev. 2004 Feb;13(2):330-1.
    14973095
  • Duguay Y, McGrath M, Lpine J, Gagn JF, Hankinson SE, Colditz GA, Hunter DJ, Plante M, Ttu B, Blanger A, Guillemette C, De Vivo I.The functional UGT1A1 promoter polymorphism decreases endometrial cancer risk.Cancer Res. 2004 Feb 1;64(3):1202-7.
    14871858
  • McGrath M, Hankinson SE, Arbeitman L, Colditz GA, Hunter DJ, De Vivo I.Cytochrome P450 1B1 and catechol-O-methyltransferase polymorphisms and endometrial cancer susceptibility.Carcinogenesis. 2004 Apr;25(4):559-565.
    14656940
  • Han J, Hankinson SE, Ranu H, De Vivo I, Hunter DJ.Polymorphisms in DNA double-strand break repair genes and breast cancer risk in the Nurses' Health Study.Carcinogenesis. 2004 Feb;25(2):189-95.
    14578164
  • Memisoglu A, Hu FB, Hankinson SE, Manson JE, De Vivo I, Willett WC, Hunter DJ.Interaction between a peroxisome proliferator-activated receptor gamma gene polymorphism and dietary fat intake in relation to body mass.Hum Mol Genet. 2003 Nov 15;12(22):2923-9.
    14506127
  • Miller DP, Neuberg D, de Vivo I, Wain JC, Lynch TJ, Su L, Christiani DC.Smoking and the risk of lung cancer: susceptibility with GSTP1 polymorphisms.Epidemiology. 2003 Sep;14(5):545-51.
    14501269
  • De Vivo I, Hankinson SE, Colditz GA, Hunter DJ.A functional polymorphism in the progesterone receptor gene is associated with an increase in breast cancer risk.Cancer Res. 2003 Sep 1;63(17):5236-8.
    14500352
  • Miller DP, De Vivo I, Neuberg D, Wain JC, Lynch TJ, Su L, Christiani DC.Association between self-reported environmental tobacco smoke exposure and lung cancer: modification by GSTP1 polymorphism.Int J Cancer. 2003 May 10;104(6):758-63.
    12640684
  • Haiman CA, Hankinson SE, De Vivo I, Guillemette C, Ishibe N, Hunter DJ, Byrne C.Polymorphisms in steroid hormone pathway genes and mammographic density.Breast Cancer Res Treat. 2003 Jan;77(1):27-36.
    12602902
  • Han J, Hankinson SE, De Vivo I, Colditz GA, Hunter DJ.No association between a stop codon polymorphism in RAD52 and breast cancer risk.Cancer Epidemiol Biomarkers Prev. 2002 Oct;11(10 Pt 1):1138-9.
    12376524
  • De Vivo I, Huggins GS, Hankinson SE, Lescault PJ, Boezen M, Colditz GA, Hunter DJ.A functional polymorphism in the promoter of the progesterone receptor gene associated with endometrial cancer risk.Proc Natl Acad Sci U S A. 2002 Sep 17;99(19):12263-8.
    12218173
  • Miller DP, Liu G, De Vivo I, Lynch TJ, Wain JC, Su L, Christiani DC.Combinations of the variant genotypes of GSTP1, GSTM1, and p53 are associated with an increased lung cancer risk.Cancer Res. 2002 May 15;62(10):2819-23.
    12019159
  • De Vivo I, Hankinson SE, Li L, Colditz GA, Hunter DJ.Association of CYP1B1 polymorphisms and breast cancer risk.Cancer Epidemiol Biomarkers Prev. 2002 May;11(5):489-92.
    12010864
  • Haiman CA, Hankinson SE, Spiegelman D, De Vivo I, Colditz GA, Willett WC, Speizer FE, Hunter DJ.A tetranucleotide repeat polymorphism in CYP19 and breast cancer risk.Int J Cancer. 2000 Jul 15;87(2):204-10.
    10861475
  • De Vivo I, Gertig DM, Nagase S, Hankinson SE, O'Brien R, Speizer FE, Parsons R, Hunter DJ.Novel germline mutations in the PTEN tumour suppressor gene found in women with multiple cancers.J Med Genet. 2000 May;37(5):336-41.
    10807691
  • De Vivo I, Cui X, Domen J, Cleary ML.Growth stimulation of primary B cell precursors by the anti-phosphatase Sbf1.Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9471-6.
    9689104
  • Cui X, De Vivo I, Slany R, Miyamoto A, Firestein R, Cleary ML.Association of SET domain and myotubularin-related proteins modulates growth control.Nat Genet. 1998 Apr;18(4):331-7.
    9537414
  • Chang CP, de Vivo I, Cleary ML.The Hox cooperativity motif of the chimeric oncoprotein E2a-Pbx1 is necessary and sufficient for oncogenesis.Mol Cell Biol. 1997 Jan;17(1):81-8.
    8972188